Cargando…

Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles

Several COVID-19 vaccine strategies utilizing new formulations for the induction of neutralizing antibodies (nAbs) and T cell immunity are still under evaluation in preclinical and clinical studies. Here we used Simian Immunodeficiency Virus (SIV)-based integrase defective lentiviral vector (IDLV) d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borghi, Martina, Gallinaro, Alessandra, Pirillo, Maria Franca, Canitano, Andrea, Michelini, Zuleika, De Angelis, Maria Laura, Cecchetti, Serena, Tinari, Antonella, Falce, Chiara, Mariotti, Sabrina, Capocefalo, Antonio, Chiantore, Maria Vincenza, Iacobino, Angelo, Di Virgilio, Antonio, van Gils, Marit J., Sanders, Rogier W., Lo Presti, Alessandra, Nisini, Roberto, Negri, Donatella, Cara, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113491/ https://www.ncbi.nlm.nih.gov/pubmed/37090707 http://dx.doi.org/10.3389/fimmu.2023.1147953

Ejemplares similares

Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
por: Morante, Valeria, et al.
Publicado: (2021)

Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice
por: Gallinaro, Alessandra, et al.
Publicado: (2020)

Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization
por: Bona, Roberta, et al.
Publicado: (2021)

Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
por: Gallinaro, Alessandra, et al.
Publicado: (2018)

Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers
por: Gallinaro, Alessandra, et al.
Publicado: (2022)

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
por: Negri, Donatella RM, et al.
Publicado: (2012)

Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency
por: Mariotti, Sabrina, et al.
Publicado: (2021)

Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
por: Rossi, Alessandra, et al.
Publicado: (2014)

Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
por: Michelini, Zuleika, et al.
Publicado: (2020)

New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis
por: Mariotti, Sabrina, et al.
Publicado: (2023)

Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice
por: Fontana, Judith M., et al.
Publicado: (2014)

Intranasal Administration of Integrase Defective Lentiviral Vectors Expressing mAbs Protects from H5 Influenza Virus Challenge In Vivo
por: Michelini, Zuleika, et al.
Publicado: (2017)

Multivalent interactions essential for lentiviral integrase function
por: Ballandras-Colas, Allison, et al.
Publicado: (2022)

Structural Basis for Functional Tetramerization of Lentiviral Integrase
por: Hare, Stephen, et al.
Publicado: (2009)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

Use of Integrase-Minus Lentiviral Vector for Transient Expression
por: Farazmandfar, Touraj, et al.
Publicado: (2012)

Skeletal Muscle Is an Antigen Reservoir in Integrase-Defective Lentiviral Vector-Induced Long-Term Immunity
por: Lin, Yi-Yu, et al.
Publicado: (2020)

The Interaction Between Lentiviral Integrase and LEDGF: Structural and Functional Insights
por: Hare, Stephen, et al.
Publicado: (2009)

Integrase deficient lentiviral vector: prospects for safe clinical applications
por: Yew, Chee-Hong Takahiro, et al.
Publicado: (2022)

Improving the Transduction of Bone Marrow–Derived Cells with an Integrase-Defective Lentiviral Vector
por: Pay, S. Louise, et al.
Publicado: (2018)

Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses
por: Mahesh, Sneha, et al.
Publicado: (2023)

Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery
por: Taltynov, Oliver, et al.
Publicado: (2012)

Nonintegrating Lentiviral Vector-Based Vaccine Efficiently Induces Functional and Persistent CD8+ T Cell Responses in Mice
por: Negri, Donatella R. M., et al.
Publicado: (2010)

The Lentiviral Integrase Binding Protein LEDGF/p75 and HIV-1 Replication
por: Engelman, Alan, et al.
Publicado: (2008)

LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro
por: Cherepanov, Peter
Publicado: (2007)

Hepatocyte-Targeted Expression by Integrase-Defective Lentiviral Vectors Induces Antigen-Specific Tolerance in Mice with Low Genotoxic Risk
por: Mátrai, Janka, et al.
Publicado: (2011)

Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization
por: Dispinseri, Stefania, et al.
Publicado: (2022)

Strong SARS-CoV-2 N-Specific CD8(+) T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
por: Ferrantelli, Flavia, et al.
Publicado: (2022)

Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing
por: Ortinski, Pavel I., et al.
Publicado: (2017)

Lentiviral Protein Transduction with Genome-Modifying HIV-1 Integrase-I-PpoI Fusion Proteins: Studies on Specificity and Cytotoxicity
por: Turkki, Vesa, et al.
Publicado: (2014)

Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cells
por: Shapira, Shiran, et al.
Publicado: (2021)

Lentiviral Vector Bioprocessing
por: Perry, Christopher, et al.
Publicado: (2021)

phiC31 Integrase-Mediated Site-Specific Recombination in Barley
por: Kapusi, Eszter, et al.
Publicado: (2012)

HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein
por: Cianfriglia, Maurizio, et al.
Publicado: (2007)

Antiviral effect of SARS-CoV-2 N-specific CD8(+) T cells induced in lungs by engineered extracellular vesicles
por: Manfredi, Francesco, et al.
Publicado: (2023)

SARS-CoV-2-Specific CD8(+) T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection
por: Ferrantelli, Flavia, et al.
Publicado: (2023)

Immunological profile of an infant treated with integrase inhibitor from the neonatal period
por: Taramasso, Lucia, et al.
Publicado: (2019)

The Inside Out of Lentiviral Vectors
por: Durand, Stéphanie, et al.
Publicado: (2011)

Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant
por: Qamar Saeed, Muhammad, et al.
Publicado: (2014)

Integrase and integration: biochemical activities of HIV-1 integrase
por: Delelis, Olivier, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fj31nqng4jdrohqvpvrp8l3p8p